News
1d
News Medical on MSNMissing gene regulator accelerates disc aging and spinal degenerationAs populations worldwide continue to age, chronic back pain caused by intervertebral disc degeneration is emerging as a ...
The company is one of the first to receive a “platform technology designation,” which could speed the review of certain gene ...
Health and Human Services Secretary Robert F. Kennedy Jr. said on Thursday that the U.S. drugs regulator would look for ways ...
As populations worldwide continue to age, chronic back pain caused by intervertebral disc degeneration is emerging as a widespread and costly health ...
The Platform Technology Designation, which predates the current FDA leadership, is designed to streamline the drug ...
Hosted on MSN2mon
'Master regulator' gene could lead to more effective treatment for patients with ovarian cancerMore information: Lora Stojanovic et al, ZNFX1 Functions as a Master Regulator of Epigenetically Induced Pathogen Mimicry and Inflammasome Signaling in Cancer, Cancer Research (2025). DOI: 10.1158 ...
Vinay Prasad, a critic of the Food and Drug Administration, has been tapped as the agency’s top regulator of vaccines, gene therapies and the blood supply.
The researchers described the unprecedented speed of the oversight steps as being "through alternative procedures." In month five, they started toxicology testing in mice. In the mice, the ...
Among its most significant effects is the modification of both histone and non-histone proteins, influencing critical pathways such as gene transcription, chromatin remodeling, cell signaling ...
The influenza virus manipulates the body's gene regulation system to accelerate its own spread, according to researchers at the University of Gothenburg. Their study also shows that an already ...
Other contributions represent the University of Pennsylvania and Samsung Medical Center in Seoul, South Korea. A master regulator gene, FOXG1 is one of the most important genes for early brain ...
Get Instant Summarized Text (Gist) The gene ZNFX1 has been identified as a "master regulator" that could serve as a biomarker for guiding treatment in therapy-resistant ovarian cancer. High levels ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results